Welcome to BDA

  "The future of molecular targeted therapy requires a detailed understanding of translational R&D and economics."


Home Navigation Navigation Pre-clinical Navigation Clinical Navigation News Navigation Events Navigation Links Navigation Contacts Navigation Information

    Wed 08 Sep 2010

Latest BDA Events
8th – 10th September 2010
Biotherapy of Cancer (BTOC 10)
Klinikum der Universität München
Programme
Register
_______________________

Latest events

 
BDA Information
Click here to request information from BDA

Change text size

© 2009 Biotherapy Development Association




Clinical services
 
BDA researchers have extensive experience in cancer drug development, with particular strengths in early drug development with biological agents. Our clinical services include:

  • Design of early clinical study protocols for solid tumour / haematological malignancies including the definition of surrogate markers and optimal biologically active dose to optimise the drug development programs.
  • Advise on appropriate drug development strategies, clinical trial designs and latest trends in biotherapy development.
  • Advise on the organisation of translational research accompanying early clinical studies
  • Advise on strategies in combining biologicals with conventional anti-cancer drugs and therapies.
  • Perform GCP-compliant clinical studies in our global network of centers.
  • Carry out ongoing assessment of treatment response (both clinical and biological) to determine the optimal dose and schedule.
  • Analyze and evaluate surrogate markers.

















Web site created and maintained using   link to web4work